Structure, Value, and Close Biotech & Pharma Deals
For BD, Licensing, and Strategy Teams Working on Live Transactions
Intensive 2-day masterclasses for business development, licensing, and strategy teams working on real transactions.
Develop the commercial capability to structure, value, and execute biotech and pharma deals.
Delivered exclusively to individuals or single teams – no public courses.
9–10 June 2026
Negotiate, structure, and close biotech and pharma deals with confidence.
Gain practical experience in preparing and executing complex partnership and licensing agreements. Learn how to identify the right partner, structure win-win deals, and maximise intellectual property value through strategic licensing.
You’ll learn how to:
• Formulate deal structures that reflect true asset value
• Negotiate effectively with multiple stakeholder groups
• Apply financial models that simulate real-world scenarios
• Create sustainable agreements that drive long-term success
Ideal for: business development, licensing and legal professionals managing high-value transactions.
9–10 June 2026
Build stronger, smarter, and more profitable pharma partnerships
Understand the strategic imperatives that drive collaboration in today’s pharmaceutical ecosystem. Discover how to approach the right partner, structure agreements that enhance pipeline performance, and manage partnerships for mutual growth.
You’ll learn how to:
• Identify and evaluate potential partners
• Build sustainable frameworks for joint success
• Apply tools for effective partnership governance
• Align business and scientific objectives
Perfect for professionals involved in alliance management, business development, and strategic collaborations.
9–10 June 2026
Accelerate discovery, development, and access for rare-disease therapies.
Gain comprehensive insight into the orphan drug and cell- and gene-therapy landscape. Learn how to streamline clinical trials, achieve regulatory approval faster, and deliver breakthrough treatments to patients in need.
You’ll learn how to:
• Optimise R&D and approval pathways for orphan products
• Navigate reimbursement and pricing complexities
• Build next-generation value evidence for market access
• Apply adaptive clinical trial strategies
Designed for R&D, regulatory, and market-access professionals driving innovation in rare diseases.
Additional Specialist Modules
Available as standalone or integrated into tailored Programmes
-
2 Day Pharmaceutical License Valuation
9–10 June 2026
Confidently assess and negotiate high-stakes pharma licensing deals.
Master valuation techniques and deal-making strategies to determine the fair value of assets and partnerships. Learn how to apply standard methods like DCF and NPV, model long-term growth, and craft winning deal terms that maximise commercial potential.
-
2 Day Masterclass Generics
9–10 June 2026
Understand the global generics market and plan your growth strategy.
Learn how generics companies navigate competition, regulation, and profitability in a rapidly changing landscape. Explore key drivers of market share, pricing, and lifecycle management.
-
2 Day Precision Medicine
9–10 June 2026
Leverage genetics and data to transform patient outcomes.
Gain a comprehensive understanding of precision medicine – from emerging technologies and biomarkers to commercialisation and real-world application. Learn how to translate genomic discoveries into scalable healthcare solutions.
What Past Attendees Say
5Training
Empowering professionals with expert-led corporate training in Biotech, Pharma, and Renewable Energy.
Contact
International House, 64 Nile Street, London N1 7SR
+44 (0) 781 628 5327